Related Experiment Video
Updated: May 29, 2026
05:10
Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
Published on: December 11, 2016
Projected growth in pharmacy education and research, 2010 to 2015
Katherine K Knapp1, Michael Manolakis, Andrew A Webster
1Touro University College of Pharmacy, Vallejo, CA 94592, USA. katherine.knapp@tu.edu
American Journal of Pharmaceutical Education
|September 21, 2011
Summary
Pharmacy education and research are projected to grow significantly between 2010 and 2015, with the highest growth in residencies/fellowships. This expansion reflects a developing research enterprise in the field.
Area of Science:
- Pharmacy Education
- Health Professions Research
Background:
- Pharmacy education and research are critical components of healthcare.
- Understanding growth trends is essential for strategic planning and resource allocation.
Purpose of the Study:
- To project the growth of pharmacy education and research from 2010 to 2015.
- To analyze the influence of internal and external factors on projected growth.
Main Methods:
- An e-mail survey was distributed to US pharmacy deans.
- Responses were used to estimate growth in graduates, residents, fellows, students, and faculty.
- Data were correlated with economic trends, faculty vacancies, and healthcare reforms.
Main Results:
- Projected 5-year growth: 58% for residents/fellows, 23% for postdoctoral fellows, 21% for PharmD graduates.
- Graduate education and research show an expanding enterprise.
- Downward trends in faculty vacancies suggest improved faculty availability.
Conclusions:
- Significant growth is anticipated across all pharmacy education sectors by 2015.
- Actual growth rates may be influenced by external economic factors and the profession's ability to address healthcare challenges.
More Related Videos
Related Concept Videos
01:15Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure (CHF).
01:22Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
01:15Drug Dosing: Geriatric Patients
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
01:26Pharmaceutical Poisoning: Potential Scenarios
Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
01:27Pharmacodynamics in Geriatric Patients: Effects of Age
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
01:24Pharmacokinetic–Pharmacodynamic Relationship: Problems
The empirical approach to drug therapy optimization relies on correlating pharmacological response with administered dosage. Such an approach can be costly, time-consuming, and often yields poor correlation due to variables like formulation factors and drug elimination characteristics. A more precise approach correlates response with plasma drug concentration or the amount of drug in the body, rather than dosage. This is achieved through pharmacokinetic-pharmacodynamic (PK/PD) modeling, which...